| 14/03/25 | 07:00:12 | 14 Mar 2025 | | Monthly Valuation Update and Factsheet |
| 13/03/25 | 07:00:04 | 13 Mar 2025 | | Transaction in Own Shares |
| 10/03/25 | 07:00:13 | 10 Mar 2025 | | Notice of Annual Results |
| 07/03/25 | 07:00:06 | 7 Mar 2025 | | Transaction in Own Shares |
| 26/02/25 | 07:00:07 | 26 Feb 2025 | | RTW CIO increases position to 15% |
| 25/02/25 | 13:00:00 | 25 Feb 2025 | | Material purchase by CIO of the Investment Manager |
| 17/02/25 | 07:00:09 | 17 Feb 2025 | | Director/PDMR Shareholding |
| 14/02/25 | 07:00:07 | 14 Feb 2025 | | Monthly Valuation Update and Factsheet |
| 28/01/25 | 07:00:08 | 28 Jan 2025 | | Material Update from Portfolio Company |
| 27/01/25 | 07:00:04 | 27 Jan 2025 | | Kailera Reports Positive Data in Ph2 Obesity Trial |
| 17/01/25 | 07:01:00 | 17 Jan 2025 | | New Investment in Series A of Windward Bio |
| 17/01/25 | 07:00:03 | 17 Jan 2025 | | Additional Investment in Umoja Biopharma |
| 15/01/25 | 07:00:06 | 15 Jan 2025 | | Monthly Valuation Update and Factsheet |
| 14/01/25 | 07:00:05 | 14 Jan 2025 | | Additional Investment in Numab Therapeutics |
| 10/01/25 | 07:00:02 | 10 Jan 2025 | | New Investment in Series A of Alesta Therapeutics |
| 30/12/24 | 07:00:03 | 30 Dec 2024 | | CORXEL Announces Two Significant Transactions |
| 20/12/24 | 12:15:00 | 20 Dec 2024 | | New Investment in Series A of Ottimo Pharma |
| 13/12/24 | 07:00:07 | 13 Dec 2024 | | Monthly Valuation Update and Factsheet |
| 10/12/24 | 12:00:00 | 10 Dec 2024 | | Holding(s) in Company |
| 10/12/24 | 07:00:07 | 10 Dec 2024 | | Appointment of Senior Independent Director |
| 15/11/24 | 07:00:01 | 15 Nov 2024 | | CORXEL Announces Acceptance of NDA for Aficamten |
| 14/11/24 | 07:00:03 | 14 Nov 2024 | | Monthly Valuation Update and Factsheet |
| 01/11/24 | 14:00:00 | 1 Nov 2024 | | New Investment in Series C Round of Evommune, Inc. |
| 01/11/24 | 07:00:02 | 1 Nov 2024 | | RTW Biotech Opportunities’ 5th Anniversary |
| 14/10/24 | 18:12:22 | 14 Oct 2024 | | Monthly Valuation Update and Factsheet Replacement |
| 14/10/24 | 07:00:01 | 14 Oct 2024 | | Monthly Valuation Update and Factsheet |
| 03/10/24 | 07:00:03 | 3 Oct 2024 | | Launch of Obesity Company Kailera Therapeutics |
| 02/10/24 | 07:00:03 | 2 Oct 2024 | | New Investment in Aktis Oncology |
| 27/09/24 | 07:00:07 | 27 Sept 2024 | | BioAge Labs completes $198 million IPO |
| 26/09/24 | 07:00:07 | 26 Sept 2024 | | GBP quote for the share class to cease |
| 16/09/24 | 07:00:06 | 16 Sept 2024 | | Monthly Valuation Update and Factsheet |
| 13/09/24 | 07:00:04 | 13 Sept 2024 | | Half-year Report |
| 14/08/24 | 07:01:01 | 14 Aug 2024 | | Closed Period Notification |
| 14/08/24 | 07:00:11 | 14 Aug 2024 | | Monthly Valuation Update and Factsheet |
| 06/08/24 | 07:00:03 | 6 Aug 2024 | | New Investment in Jade Biosciences, Inc |
| 22/07/24 | 12:00:01 | 22 Jul 2024 | | Artiva Biotherapeutics prices IPO at $167 million |
| 15/07/24 | 07:00:07 | 15 Jul 2024 | | Monthly Valuation Update and Factsheet |
| 11/07/24 | 07:00:10 | 11 Jul 2024 | | Baroness Blackwood Appointed as Independent NED |
| 02/07/24 | 07:00:07 | 2 Jul 2024 | | Investment in Mirador Therapeutics & Santa Ana Bio |
| 01/07/24 | 07:00:03 | 1 Jul 2024 | | Total Voting Rights |
| 14/06/24 | 07:00:07 | 14 Jun 2024 | | Monthly Valuation Update and Factsheet |
| 13/06/24 | 07:00:06 | 13 Jun 2024 | | Positive Data Announcement - Avidity Biosciences |
| 11/06/24 | 07:00:05 | 11 Jun 2024 | | Portfolio Company Numab Therapeutics Update |
| 05/06/24 | 07:00:05 | 5 Jun 2024 | | Transaction in Own Shares |
| 03/06/24 | 07:00:05 | 3 Jun 2024 | | Total Voting Rights |
| 31/05/24 | 12:00:00 | 31 May 2024 | | Director Declaration |
| 31/05/24 | 07:00:05 | 31 May 2024 | | Transaction in Own Shares |
| 29/05/24 | 07:00:10 | 29 May 2024 | | Holding(s) in Company |
| 28/05/24 | 07:00:18 | 28 May 2024 | | Holding(s) in Company |
| 24/05/24 | 12:00:01 | 24 May 2024 | | Cancellation of Own Shares |
